THE SCIENCE BEHIND XELJANZ

Open page of a journal

XELJANZ is a Janus kinase (JAK) inhibitor that works deep inside the cell to disrupt activities occurring in signaling pathways. These JAK pathways are believed to play a role in the inflammation associated with RA.

Watch to learn more about the science of XELJANZ and how it works to help disrupt the processes that can lead to inflammation.